GFAP and major depressive disorder: For example, in the postmortem brains of MDD patients, decreased expression of astrocytic markers, such as S100β and glial fibrillary acidic protein (GFAP), have been observed in the medial prefrontal cortex (mPFC), a brain region rendering resilience to stress8–10.